Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H<sup>+</sup>, K<sup>+</sup>-ATPases in Pancreatic Cancer and Stellate Cells.

Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H⁺, K⁺-ATPases in Pancreatic Cancer and Stellate Cells.

Tozzi, Marco; Sørensen, Christiane E; Magni, Lara; Christensen, Nynne M; Bouazzi, Rayhana; Buch, Caroline M; Stefanini, Matteo; Duranti, Claudia; Arcangeli, Annarosa; Novak, Ivana.

Afiliação

Tozzi M; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark.
Sørensen CE; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark.
Magni L; Section of Clinical Oral Microbiology, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Christensen NM; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark.
Bouazzi R; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark.
Buch CM; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark.
Stefanini M; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark.
Duranti C; Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, 50134 Florence, Italy.
Arcangeli A; DI.V.A.L. Toscana SRL, 50019 Sesto Fiorentino, Florence, Italy.
Novak I; Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, 50134 Florence, Italy.